国海证券研报指出，2025年 巨化股份归母净利润同比大幅提升，看好制冷剂景气持续。公司为制冷剂 全球龙头企业，是国内拥有第一至四代含氟制冷剂系列产品，同时拥有新型含氟冷媒（氢氟醚D系列、 全氟聚醚JHT系列）、碳氢制冷剂产品（3.5万吨/年）以及系列混配制冷剂的生产企业。公司制冷剂生 产配额优势明显，据2026年度氢氟碳化物生产、进口配额核发表，国家核定公司（含控股子公司） HCFC-22生产配额3.84万吨，占全国26.30%，其中内用配额占全国31.55%，为国内第一；HFCs生产配 额29.99万吨，占全国同类品种合计份额的37.58%。同时，公司第四代含氟制冷剂（HFOs）品种及有效 产能国内领先（现运营两套主流HFOs生产装置，产能约8000吨/年；计划通过新建+技术改造新增产能 近5万吨）。公司是全球氟制冷剂龙头企业，制冷剂生产配额领先，随着制冷剂价格上涨，公司有望充 分受益，快速发展。维持"买入"评级。 ...

国海证券研报指出，2025年巨化股份归母净利润同比大幅提升，看好制冷剂景气持续。公司为制冷剂全 球龙头企业，是国内拥有第一至四代含氟制冷剂系列产品，同时拥有新型含氟冷媒（氢氟醚D系列、全 氟聚醚JHT系列）、碳氢制冷剂产品（3.5万吨/年）以及系列混配制冷剂的生产企业。公司制冷剂生产 配额优势明显，据2026年度氢氟碳化物生产、进口配额核发表，国家核定公司（含控股子公司）HCFC- 22生产配额3.84万吨，占全国26.30%，其中内用配额占全国31.55%，为国内第一；HFCs生产配额29.99 万吨，占全国同类品种合计份额的37.58%。同时，公司第四代含氟制冷剂（HFOs）品种及有效产能国 内领先（现运营两套主流HFOs生产装置，产能约8000吨/年；计划通过新建+技术改造新增产能近5万 吨）。公司是全球氟制冷剂龙头企业，制冷剂生产配额领先，随着制冷剂价格上涨，公司有望充分受 益，快速发展。维持"买入"评级。 ...

巨化股份在日前接受机构调研时表示，2026年空调市场将保持稳定增长，预计主流三代制冷剂R32的供 需将维持紧平衡状态。随着新能源汽车快速发展，R134a的需求将会增加，供需平衡预计会更加紧张。 R125则由于内用配额比例较小和社会库存减少，其供需关系也将较为紧张。 该公司指出，制冷剂行业内部分企业存在配额品种不齐全、部分配额数量较少的情况。当高全球增温潜 势值制冷剂产品价格上涨，或企业为维护客户和渠道需要时，可能会调增高GWP值制冷剂的产量。 国信证券的观点认为，预计2026年主流三代制冷剂将保持供需紧平衡。制冷剂配额约束收紧为长期趋势 方向，在此背景下，R32、R134a、R125等主流制冷剂的景气度有望延续，价格长期仍有较大上行空 间，对应制冷剂配额龙头企业有望保持长期高盈利水平。此外，液冷产业的发展也被看好，其对氟化液 与制冷剂的需求有望提升。 在产业链动态方面，上游萤石资源龙头企业金石资源于12月21日晚间发布公告，拟斥资2.57亿元受让浙 江诺亚氟化工有限公司15.7147%的股权，交易完成后将成为其第二大股东。金石资源在公告中表示， 本次交易是公司作为氟化工上游龙头企业向下游高附加值精细氟化工领域 ...

Investment Rating - The investment rating for the company is "Buy" [9] Core Insights - The company reported a revenue of 3.79 billion yuan for the first three quarters of 2025, representing a year-on-year increase of 12.0%. The net profit attributable to shareholders reached 470 million yuan, a significant year-on-year increase of 220.4%. The net profit excluding non-recurring items was 460 million yuan, up 223.7% year-on-year. In Q3 alone, the company achieved a revenue of 1.34 billion yuan, a year-on-year increase of 11.4% and a quarter-on-quarter increase of 2.5%. The net profit for Q3 was 200 million yuan, reflecting a year-on-year increase of 485.8% and a quarter-on-quarter increase of 13.7% [2][6][12]. Summary by Sections Financial Performance - For the first three quarters of 2025, the company achieved a total revenue of 3.79 billion yuan, with a net profit of 470 million yuan and a net profit excluding non-recurring items of 460 million yuan. In Q3, the revenue was 1.34 billion yuan, with a net profit of 200 million yuan [2][6]. Market Trends - The refrigerant market continues to show positive trends, with the company’s fluorocarbon chemicals generating a revenue of 730 million yuan in Q3, a year-on-year increase of 5.9%. The average price for various refrigerants showed mixed trends, with some prices increasing significantly [12][13]. Profitability Metrics - The company’s gross margin for Q3 was 27.4%, an increase of 12.6 percentage points year-on-year, while the net margin was 14.8%, up 12.0 percentage points year-on-year. The increase in profitability is attributed to the ongoing positive trends in the refrigerant market [12][13]. Future Outlook - Looking ahead to Q4, the company anticipates continued growth in the third-generation refrigerants, while the second-generation refrigerants may face short-term pressure. The company has several projects under construction, including 80,000 tons of hydrofluoric acid and over 30,000 tons of fluoropolymer materials, which will support sustainable business development [12][13].

Investment Rating - The investment rating for the company is "Buy" [5][12] Core Views - The company reported a significant increase in revenue and net profit for the first half of 2025, with revenue reaching 13.33 billion and net profit at 2.05 billion, representing year-on-year growth of 10.36% and 145.84% respectively [2][4] - The refrigerant business continues to drive the company's performance, with the average price of fluorinated refrigerants recovering, contributing significantly to profit growth [3][4] - The company has ongoing projects that are expected to enhance future performance, including the construction of high-performance fluorinated materials projects [3] Summary by Sections Financial Performance - In 25H1, the company achieved a gross margin of 28.72% and a net margin of 17.07%, reflecting improvements of 11.99 and 9.43 percentage points year-on-year [2] - Revenue from various business segments showed diverse growth, with refrigerants up by 55.09% year-on-year [2][3] Business Segments - The company’s revenue from fluorinated chemical raw materials, refrigerants, and fluorinated fine chemicals showed significant increases, with refrigerants alone contributing 6.09 billion in revenue [2][3] Future Outlook - The company expects net profits to grow to 4.41 billion, 5.31 billion, and 6.53 billion for the years 2025, 2026, and 2027 respectively, with corresponding PE ratios of 22.16, 18.39, and 14.96 [4][11]